Plain-English translation of NCT05653973 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study investigates how low-dose aspirin (a common over-the-counter medication) may help protect blood vessels in women who had preeclampsia—a serious pregnancy condition that affects about 5–10% of pregnancies. Women who have had preeclampsia are at higher risk for heart disease later in life, and researchers want to understand why this happens and how the medication might help prevent it.
Preeclampsia can cause lasting damage to blood vessels that doesn't go away after pregnancy, which may explain why these women face higher risk of heart disease as they age. This study aims to understand the exact mechanisms of how this damage occurs and how the medication might protect against it, so doctors can better care for women after preeclampsia.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic where researchers will perform a simple, painless test on a small area of your skin (about the size of a dime). They will use a tiny tube to deliver small amounts of different substances to your skin and measure how your blood vessels respond. The researchers will also draw a small blood sample to study inflammation. The entire visit takes a few hours, and there is no ongoing treatment or medication to take at home.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States